Glucocorticoid treatment increases cholesterol availability during critical illness: effect on adrenal and muscle function-Reference-Cited by-同舟云学术

Glucocorticoid treatment increases cholesterol availability during critical illness: effect on adrenal and muscle function

Published:2024-09-05 Issue:1 Volume:28 Page:
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Crit Care

Author:

De Bruyn Lauren,Téblick Arno,Van Oudenhove Tim,Vander Perre Sarah,Derese Inge,Pauwels Lies,Derde Sarah,De Vlieger Greet,Van den Berghe Greet,Langouche Lies

Funder

European Research Council

Methusalem program of the Flemish Government

Fonds Wetenschappelijk Onderzoek

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13054-024-05079-8.pdf

Reference54 articles.

1. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab. 2004;89(1):219–26.

2. Dunham CM, Fealk MH, Sever WE 3rd. Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection. Crit Care. 2003;7(6):R145–53.

3. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ, et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med. 2001;29(8):1563–8.

4. Tanaka S, Labreuche J, Drumez E, Harrois A, Hamada S, Vigue B, et al. Low HDL levels in sepsis versus trauma patients in intensive care unit. Ann Intensive Care. 2017;7(1):60.

5. Chiarla C, Giovannini I, Giuliante F, Zadak Z, Vellone M, Ardito F, et al. Severe hypocholesterolemia in surgical patients, sepsis, and critical illness. J Crit Care. 2010;25(2):361e7-e12.